BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 1981327)

  • 1. Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study.
    Yang CR; Mogenson GJ
    Brain Res; 1990 Aug; 524(2):271-81. PubMed ID: 1981327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.
    Bertorelli R; Zambelli M; Di Chiara G; Consolo S
    J Neurochem; 1992 Jul; 59(1):353-7. PubMed ID: 1351928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R; Mantz J; Pirot S; Glowinski J; Thierry AM
    J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA; Spear LP
    Psychopharmacology (Berl); 1992; 107(1):39-49. PubMed ID: 1350350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of lithium on dopaminergic responses: iontophoretic studies in the rat visual cortex.
    Gottberg E; Montreuil B; Reader TA
    Synapse; 1988; 2(4):442-9. PubMed ID: 2903566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
    Liang RZ; Wu M; Yim CC; Mogenson GJ
    Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.
    Johansen PA; Clarkl D; White FJ
    Life Sci; 1988; 43(6):515-24. PubMed ID: 2900459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM; Mohell N; Bengtsson A; Malmberg A
    Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction.
    Shen RY; Asdourian D; Chiodo LA
    Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.